Lepu Biopharma Co. Ltd. Class H (HK:2157) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Lepu Biopharma Co., Ltd. has entered into a New Procurement Framework Agreement with Lepu Medical, continuing their established business relationship. This agreement, effective from January 1, 2025, allows Lepu Medical to supply raw materials and services crucial for Lepu Biopharma’s operations. The transactions are defined as continuing connected transactions under the Hong Kong Stock Exchange rules but do not require shareholder approval.
For further insights into HK:2157 stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- BTCC, WGMI: 2 Bitcoin ETFs for Crypto Exposure
- Shareholder Alert for PACS Group, Inc. (NYSE:PACS)
- Netflix Wins Shareholder Lawsuit Alleging Misleading Growth Forecasts
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
